Assurant
Assurant, Inc.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$12.8B
Operating marginCalculated
Could not be retrieved
Net assets to total assetsCalculated
16.2%
Company profile
Tables scroll sideways
Disclosed data
Profitability
Could not be retrieved
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
5.9%
Capital efficiency
★★★★☆position among all companies
14.9%
Revenue and profit
Performance, financial position and capital allocation
Assurant
Recent performance trends
Assurant
Cash flow trends
Consolidated indicators (8 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$10.2 billion | US$10.2 billion | US$11.1 billion | US$11.9 billion | US$12.8 billion |
| Net income | US$1.4 billion | US$0.3 billion | US$0.6 billion | US$0.8 billion | US$0.9 billion |
| Total assets | US$33.9 billion | US$33.1 billion | US$33.6 billion | US$35.0 billion | US$36.3 billion |
| Shareholders' equity | US$5.5 billion | US$4.2 billion | US$4.8 billion | US$5.1 billion | US$5.9 billion |
| Net cash provided by (used in) operating activities | US$0.8 billion | US$0.6 billion | US$1.1 billion | US$1.3 billion | US$1.8 billion |
| Net cash provided by (used in) investing activities | US$0.2 billion | US$-0.3 billion | US$-0.6 billion | US$-0.7 billion | US$-1.5 billion |
| Net cash provided by (used in) financing activities | US$-1.1 billion | US$-0.8 billion | US$-0.4 billion | US$-0.5 billion | US$-0.4 billion |
| Cash and cash equivalents | US$2.0 billion | US$1.5 billion | US$1.6 billion | US$1.8 billion | US$1.8 billion |
Revenue scale in the same industry
Assurant
Insurance carriers: 54 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 UnitedHealth Group US$447.6B
- 2 Berkshire Hathaway US$371.4B
- 3 The Cigna Group US$274.9B
- … 23 companies
- 27 Fidelity National Financial US$14.4B
- 28 Unum Group US$13.1B
- 29 AssurantThis company US$12.8B
- 30 Cincinnati Financial US$12.6B
- 31 Oscar Health US$11.7B
- … 23 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.2 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$1.8 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.4 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-1.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$1.8 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.2 billion | Consolidated | Disclosed |
| Dividends paid | US$0.2 billion | Consolidated | Disclosed |
| Net assets | US$5.9 billion | Consolidated | Disclosed |
| Net sales | US$12.8 billion | Consolidated | Disclosed |
| Net income | US$0.9 billion | Consolidated | Disclosed |
| Total assets | US$36.3 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.3 billion | Consolidated | Disclosed |
| Operating margin | Cannot be calculated | Not applicable | Not calculated (no operating income in this year's 10-K) |
| Net assets to total assets | 16.2% | Consolidated | Calculated |
| Net margin | 6.8% | Consolidated | Calculated |
| Return on equity | 14.9% | Consolidated | Calculated |